These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

752 related items for PubMed ID: 9364988

  • 1. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor.
    Rupin A, Mennecier P, Lila C, de Nanteuil G, Verbeuren TJ.
    Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988
    [Abstract] [Full Text] [Related]

  • 2. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
    Costanzo MJ, Almond HR, Hecker LR, Schott MR, Yabut SC, Zhang HC, Andrade-Gordon P, Corcoran TW, Giardino EC, Kauffman JA, Lewis JM, de Garavilla L, Haertlein BJ, Maryanoff BE.
    J Med Chem; 2005 Mar 24; 48(6):1984-2008. PubMed ID: 15771442
    [Abstract] [Full Text] [Related]

  • 3. Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches.
    Bhunia SS, Roy KK, Saxena AK.
    J Chem Inf Model; 2011 Aug 22; 51(8):1966-85. PubMed ID: 21761917
    [Abstract] [Full Text] [Related]

  • 4. Development of plasma kallikrein selective inhibitors.
    Okada Y, Tsuda Y, Tada M, Wanaka K, Hijikata-Okunomiya A, Okamoto U, Okamoto S.
    Biopolymers; 1999 Aug 22; 51(1):41-50. PubMed ID: 10380351
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The selective inhibition of thrombin by peptides of boroarginine.
    Kettner C, Mersinger L, Knabb R.
    J Biol Chem; 1990 Oct 25; 265(30):18289-97. PubMed ID: 2211702
    [Abstract] [Full Text] [Related]

  • 7. A family of arginal thrombin inhibitors related to efegatran.
    Smith GF, Shuman RT, Craft TJ, Gifford DS, Kurz KD, Jones ND, Chirgadze N, Hermann RB, Coffman WJ, Sandusky GE, Roberts E, Jackson CV.
    Semin Thromb Hemost; 1996 Oct 25; 22(2):173-83. PubMed ID: 8807715
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of tannins from Geum japonicum on the catalytic activity of thrombin and factor Xa of blood coagulation cascade.
    Dong H, Chen SX, Kini RM, Xu HX.
    J Nat Prod; 1998 Nov 25; 61(11):1356-60. PubMed ID: 9834152
    [Abstract] [Full Text] [Related]

  • 11. Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.
    Gresele P, Momi S, Berrettini M, Nenci GG, Schwarz HP, Semeraro N, Colucci M.
    J Clin Invest; 1998 Feb 01; 101(3):667-76. PubMed ID: 9449701
    [Abstract] [Full Text] [Related]

  • 12. Antithrombotic and anticoagulant profiles of TAK-442, a novel factor Xa inhibitor, in a rabbit model of venous thrombosis.
    Kawamura M, Konishi N, Hiroe K, Shofuda K, Imaeda Y, Fujimoto T, Kubo K.
    J Cardiovasc Pharmacol; 2010 Aug 01; 56(2):156-61. PubMed ID: 20410831
    [Abstract] [Full Text] [Related]

  • 13. Structure-based design of residue 1 analogs of the direct thrombin inhibitor pentapeptide FM 19.
    Girnys EA, Sobczyk-Kojiro K, Mosberg HI.
    Chem Biol Drug Des; 2010 Jan 01; 75(1):35-9. PubMed ID: 19954432
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Ultrasensitive fluorogenic substrates for serine proteases.
    Butenas S, DiLorenzo ME, Mann KG.
    Thromb Haemost; 1997 Oct 01; 78(4):1193-201. PubMed ID: 9364984
    [Abstract] [Full Text] [Related]

  • 16. Design and characterization of dipetacompinR10H, a dipetalogastin II-derived, classical competitive thrombin inhibitor.
    Bitter T, López M, Nowak G.
    Thromb Haemost; 2007 Jan 01; 97(1):139-45. PubMed ID: 17200781
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Fibrinolytic compromise by simultaneous administration of site-directed inhibitors of thrombin.
    Callas D, Bacher P, Iqbal O, Hoppensteadt D, Fareed J.
    Thromb Res; 1994 May 01; 74(3):193-205. PubMed ID: 8042188
    [Abstract] [Full Text] [Related]

  • 19. Design and synthesis of peptide inhibitors of blood coagulations.
    Bajusz S, Széll E, Barabás E, Bagdy D.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982 May 01; 109(1):16-21. PubMed ID: 6177598
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.